Canada markets closed

Cerus Corporation (CERS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.43+0.34 (+6.68%)
At close: 04:00PM EDT
5.45 +0.02 (+0.37%)
After hours: 06:12PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close5.09
Open5.29
Bid5.04 x 3200
Ask5.59 x 2900
Day's Range5.14 - 5.43
52 Week Range4.35 - 8.06
Volume1,907,444
Avg. Volume1,928,493
Market Cap961.599M
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-0.29
Earnings DateOct 31, 2022 - Nov 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.40
  • Motley Fool

    Cerus (CERS) Q2 2022 Earnings Call Transcript

    Thank you for standing by, and welcome to the Cerus Corporation second quarter 2022 earnings conference call. With me on the call are Obi Greenman, Cerus' president and chief executive officer; Kevin Green, Cerus' chief financial officer; Vivek Jayaraman, Cerus' chief operating officer; Dr. Nina Mufti, Cerus' vice president, development, and red blood cell program Leader; Dr. Richard Benjamin, Cerus' chief medical officer; Carol Moore, Cerus' senior vice president of regulatory affairs and quality; and Jessica Hanover, Cerus' vice president of corporate affairs.

  • Zacks

    Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates

    Cerus (CERS) delivered earnings and revenue surprises of 16.67% and 2.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Cerus Corporation Announces Another Record Quarter and Reiterates Full Year 2022 Product Revenue Guidance Range

    CONCORD, Calif., August 04, 2022--Cerus Corporation (Nasdaq: CERS) today announced financial results for the second quarter ended June 30, 2022.